- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Results
115
Most Popular Stocks on the market
115 companies
Clover Biopharmaceuticals
Market Cap: HK$2.9b
A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.
2197
HK$2.26
7D
7.1%
1Y
707.1%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.13
7D
-4.5%
1Y
120.2%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$2.7b
A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.
2566
HK$11.13
7D
-10.5%
1Y
n/a
SinoMab BioScience
Market Cap: HK$2.6b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
3681
HK$1.88
7D
0%
1Y
54.1%
Frontage Holdings
Market Cap: HK$2.5b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.25
7D
-8.8%
1Y
71.2%
Zhejiang Taimei Medical Technology
Market Cap: HK$2.4b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$4.33
7D
-0.9%
1Y
n/a
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.96
7D
-2.3%
1Y
211.6%
HighTide Therapeutics
Market Cap: HK$2.3b
A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.
2511
HK$4.02
7D
-3.1%
1Y
390.2%
Immunotech Biopharm
Market Cap: HK$2.2b
A cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China.
6978
HK$4.35
7D
-9.0%
1Y
77.6%
Transcenta Holding
Market Cap: HK$2.1b
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$4.60
7D
8.7%
1Y
342.3%
Genor Biopharma Holdings
Market Cap: HK$2.1b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$3.94
7D
-5.5%
1Y
n/a
Zhaoke Ophthalmology
Market Cap: HK$2.0b
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.
6622
HK$3.65
7D
-3.9%
1Y
166.4%
3D Medicines
Market Cap: HK$1.8b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.50
7D
-7.3%
1Y
177.8%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.22
7D
0.8%
1Y
8.0%
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.8b
A synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.
2563
HK$8.33
7D
-2.7%
1Y
n/a
BioDlink International
Market Cap: HK$1.7b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$2.26
7D
2.3%
1Y
11.3%
JW (Cayman) Therapeutics
Market Cap: HK$1.7b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$4.14
7D
-18.2%
1Y
202.2%
Sirnaomics
Market Cap: HK$1.5b
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$14.51
7D
-14.6%
1Y
359.2%
Brii Biosciences
Market Cap: HK$1.4b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.93
7D
-7.2%
1Y
77.1%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.30
7D
-8.4%
1Y
93.3%
CANbridge Pharmaceuticals
Market Cap: HK$1.3b
A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.
1228
HK$2.52
7D
-3.4%
1Y
712.9%
Wuhan YZY Biopharma
Market Cap: HK$1.2b
A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.
2496
HK$6.30
7D
5.4%
1Y
6.6%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.14
7D
-1.4%
1Y
62.1%
Sunho Biologics
Market Cap: HK$1.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.
2898
HK$7.94
7D
1.0%
1Y
53.9%
Kintor Pharmaceutical
Market Cap: HK$1.1b
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$2.48
7D
-8.1%
1Y
150.5%
Uni-Bio Science Group
Market Cap: HK$877.8m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.15
7D
-3.3%
1Y
77.1%
Pak Fah Yeow International
Market Cap: HK$769.8m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.47
7D
-0.4%
1Y
-4.3%
China NT Pharma Group
Market Cap: HK$721.4m
An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$1.07
7D
-7.8%
1Y
422.0%
Fusen Pharmaceutical
Market Cap: HK$584.0m
An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.
1652
HK$0.79
7D
-23.3%
1Y
-21.0%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$578.6m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.67
7D
-6.9%
1Y
-34.3%
Austar Lifesciences
Market Cap: HK$548.5m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$1.07
7D
-5.3%
1Y
91.1%
Modern Chinese Medicine Group
Market Cap: HK$525.6m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.73
7D
-1.4%
1Y
124.6%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$478.2m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.42
7D
-7.6%
1Y
123.7%
Tianda Pharmaceuticals
Market Cap: HK$354.8m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.17
7D
4.4%
1Y
-30.1%
Extrawell Pharmaceutical Holdings
Market Cap: HK$285.6m
An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.11
7D
-3.4%
1Y
239.4%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$255.1m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.15
7D
-0.7%
1Y
-0.7%